N. Indrawattana

Molecular Medicine · 2016

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom N. Indrawattana trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. L. Rice
  2. G. Jacoby

Papers from N. Indrawattana's perspective

Ordered by how strongly the researchers N. Indrawattana trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. (Journal of Infectious Diseases)
  2. The rise of the Enterococcus: beyond vancomycin resistance (Nature Reviews Microbiology)
  3. Updated Functional Classification of β-Lactamases (Antimicrobial Agents and Chemotherapy)
  4. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (Lancet. Infectious Diseases (Print))
  5. Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 (Public health reports (1974))
  6. Γ and B
  7. AmpC β-Lactamases (Clinical Microbiology Reviews)
  8. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. (Clinical Infectious Diseases)
  9. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (Clinical Infectious Diseases)
  10. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. (Journal of the American Medical Association (JAMA))

Their papers